摘要
目的评价痰热清注射液(简称痰热清)治疗急性支气管炎的疗效及安全性。方法40例急性支气管炎随机分为两组;有风温肺热病属痰热阻肺症(简称痰热阻肺症)者为A组22例(男性14例,女性8例);否则为B组18例(男性12例,女性6例)。均以痰热清20ml,加入到5%葡萄糖注射液500ml内静脉点滴qd,疗程为7天。结果A、B两组的痊愈率分别为63.3%和11.1%,有效率分别为95.5%和50.O%,A、B组差别有显著意义(P<0.05)。结论痰热清是治疗痰热阻肺症的急性支气管炎安全有效的药物。
Objective To evaluate the clinical efficacy and safety of Tanreqing in treating acute bronchitis. Methods Forty patients were divided into two groups: Group A with tan-re-zu-fei-zheng (n = 22, 14 men and 8 women); and Group B (n = 18, 12 men and 6 women). The two groups were treated with tanreqing 20ml + 5%GS 500ml, iv, gtt, qd for 7 days. Results The total recovery rates of group A and group B were 63. 6% and 11.1 % , the effective rates were 95. 5% and 50. 0%, respectively. Conclusion Tanreqing is safe and effective in the treatment of acute bronchitis with tan-re-zu-fei-zheng
出处
《临床肺科杂志》
2005年第2期195-196,共2页
Journal of Clinical Pulmonary Medicine
